NCT00112892View on ClinicalTrials.gov

Irinotecan and Selenium in Treating Patients With Advanced Solid Tumors

PHASE1CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

August 31, 2004

Primary Completion Date

September 30, 2007

Study Completion Date

December 31, 2007

Conditions
Unspecified Adult Solid Tumor, Protocol Specific
Interventions
DIETARY_SUPPLEMENT

selenium

DRUG

irinotecan hydrochloride

Trial Locations (1)

14263-0001

Roswell Park Cancer Institute, Buffalo

All Listed Sponsors
lead

Roswell Park Cancer Institute

OTHER

NCT00112892 - Irinotecan and Selenium in Treating Patients With Advanced Solid Tumors | Biotech Hunter | Biotech Hunter